Printer Friendly

CUSTOMEDIX REPORTS RESULTS

 OLDWICK, N.J., Feb. 4 /PRNewswire/ -- Customedix Corporation (AMEX: CUS; BSE: CUSB), a health care products company, today released the company's operating results for the three and six months periods ended Dec. 31, 1992.
 For the three month period ended Dec. 31, 1992, Customedix generated net income of $187,889, or 5 cents per share, versus a net loss of $1,967,626, or 60 cents per share, for the three month period ended Dec. 31, 1991. Net income for the six mon month period ended Dec. 31, 1991.
 The 1991 losses resulted from the company discontinuing the operations of its subsidiary, Automatic Injection Molding, Inc., which resulted in a loss of $2,193,506 for the six months ended Dec. 31, 1991 and $2,145,957 for the three months ended Dec. 31, 1991.
 Sales for the three month period ended Dec. 31, 1992 were $10,781,776 versus $8,941,873 for the three month period ended Dec. 31, 1991, an increase of 21 percent. For the six month period ended Dec. 31, 1992, sales were $19,984,490 versus $17,172,294 for the six month period ended Dec. 31, 1991, an increase of 16 percent.
 CUSTOMEDIX CORPORATION
 Condensed Consolidated Statements of Operations
 (Unaudited)
 Periods ended Quarter Six months
 Dec. 31 1992 1991 1992 1991
 Sales 10,781,776 8,941,873 19,984,490 17,172,294
 Income from
 cont. oper. bef.
 income taxes 301,639 227,331 543,975 130,173
 Income taxes (A) 113,750 49,000 177,500 76,500
 Income from cont.
 operations 187,889 178,331 366,475 53,673
 Loss on discont.
 oper. (B) -- (2,145,957) -- (2,193,506)
 Net income (loss) 187,889 (1,967,626) 366,475 (2,139,833)
 Income per share
 from cont. oper. .05 .06 .10 .01
 Net income (loss)
 per share .05 (.60) .10 (.66)
 Weighted average
 shares outstdg. 3,700,500 3,264,300 3,712,300 3,264,600
 Condensed Consolidated Balance Sheet
 Dec. 31, 1992 June 30, 1992
 (Unaudited) (Audited)
 Assets
 Cash and cash equivalents $ 283,574 $ 745,457
 Receivables 6,102,364 5,863,934
 Inventory 6,077,157 5,526,166
 Other 316,936 293,464
 Total current assets 12,780,031 12,429,021
 Property and equipment, net 2,983,850 2,958,500
 Other 6,543,582 6,732,726
 Total assets 22,307,463 22,120,247
 Liabilities
 Payables and accrued expenses 4,282,279 3,944,105
 Current portion of long term
 debt and capital lease oblig. 560,271 737,110
 Total current liabilities 4,842,550 4,681,215
 Long term debt and capital lease
 obligations 8,777,675 9,050,162
 Total liabilities 13,620,225 13,731,377
 Stockholders' equity:
 Common stock and additional
 paid-in capital 27,432,877 27,500,986
 Accumulated deficit (18,745,639) (19,112,116)
 Total stockholders' equity 8,687,238 8,388,870
 Total liabilities and
 stockholders' equity 22,307,463 22,120,247
 (A) -- Taxes on income represent state income taxes and certain minimum federal income taxes which are less than the statutory rate due to the availability of net loss carryforwards.
 (B) -- The company's subsidiary, Automatic Injection Molding, Inc., was discontinued as of Dec. 31, 1991 and the results of its operations have been excluded from the company's continuing operations for the periods presented.
 -0- 2/4/93
 /CONTACT: Joe MacDougald of Customedix Corporation, 203-265-7397/
 (CUS)


CO: Customedix Corporation ST: New Jersey IN: MTC SU: ERN

TS-KW -- NY112 -- 3177 02/04/93 16:35 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 4, 1993
Words:592
Previous Article:MOBIL NETHERLANDS SHARES IN DUTCH EXPLORATION SUCCESS
Next Article:BAROID CORPORATION ANNOUNCES FIRST QUARTER DIVIDEND


Related Articles
CUSTOMEDIX REPORTS FIRST QUARTER FINANCIAL RESULTS
CUSTOMEDIX REPORTS RESULTS
CUSTOMEDIX REPORTS RESULTS
CUSTOMEDIX REPORTS FISCAL FINANCIAL RESULTS FOR ITS FIRST QUARTER OF FISCAL 1993
CUSTOMEDIX CORPORATION REPORTS SETTLEMENT OF LITIGATION
CUSTOMEDIX EXTENDS EMPLOYMENT AGREEMENT AND REPURCHASES SHARES FORM SUBSIDIARY OFFICER
CUSTOMEDIX CORPORATION BOARD APPROVES MERGER
Customedix Corporation Order and Final Judgment Entered in Delaware Litigation
Customedix Corporation Stockholders Approve Merger

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters